Effect of sertraline on [Ca2+]i and viability of human MG63 osteosarcoma cells. (April 2013)
- Record Type:
- Journal Article
- Title:
- Effect of sertraline on [Ca2+]i and viability of human MG63 osteosarcoma cells. (April 2013)
- Main Title:
- Effect of sertraline on [Ca2+]i and viability of human MG63 osteosarcoma cells
- Authors:
- Lin, Ko-Long
Chi, Chao-Chuan
Lu, Ti
Tseng, Li-Ling
Wang, Jue-Long
Lu, Yi-Chau
Jan, Chung-Ren - Abstract:
- <abstract> <title> <x xml:space="preserve">Abstract</x> </title> <p>The antidepressant, sertraline, has been shown to have diverse <italic>in vitro</italic> effects. This study examined whether sertraline altered [Ca<sup>2+</sup>]<sub>i</sub> in MG63 human osteosarcoma cells by using fura-2 as a Ca<sup>2+</sup>-sensitive fluorescent dye. At 50–200 µM, sertraline induced a [Ca<sup>2+</sup>]<sub>i</sub> rise in a concentration-dependent manner. Ca<sup>2+</sup> response was decreased by removing extracellular Ca<sup>2+</sup>, suggesting that Ca<sup>2+</sup> entry and release contributed to the [Ca<sup>2+</sup>]<sub>i</sub> signal. Sertraline-induced Ca<sup>2+</sup> entry was inhibited by nifedipine, La<sup>3+</sup>, Gd<sup>3+</sup>, and SK&amp;F96365. When extracellular Ca<sup>2+</sup> was removed, pretreatment with the endoplasmic reticulum (ER) Ca<sup>2+</sup> pump inhibitor, thapsigargin, or 2, 5-di-tert-butylhydroquinone (BHQ) abolished the sertraline-evoked [Ca<sup>2+</sup>]<sub>i</sub> rise. Incubation with sertraline also abolished the thapsigargin or BHQ-induced [Ca<sup>2+</sup>]<sub>i</sub> rise. Inhibition of phospholipase C (PLC) with U73122 abolished the sertraline-induced [Ca<sup>2+</sup>]<sub>i</sub> rise. At 20–30 µM, overnight treatment with sertraline killed cells in a concentration-dependent manner. The cytotoxic effect of sertraline was not reversed by chelating cytosolic Ca<sup>2+</sup> with 1, 2-bis(2-aminophenoxy)ethane-N, N, N', N'-tetraacetic acid<abstract> <title> <x xml:space="preserve">Abstract</x> </title> <p>The antidepressant, sertraline, has been shown to have diverse <italic>in vitro</italic> effects. This study examined whether sertraline altered [Ca<sup>2+</sup>]<sub>i</sub> in MG63 human osteosarcoma cells by using fura-2 as a Ca<sup>2+</sup>-sensitive fluorescent dye. At 50–200 µM, sertraline induced a [Ca<sup>2+</sup>]<sub>i</sub> rise in a concentration-dependent manner. Ca<sup>2+</sup> response was decreased by removing extracellular Ca<sup>2+</sup>, suggesting that Ca<sup>2+</sup> entry and release contributed to the [Ca<sup>2+</sup>]<sub>i</sub> signal. Sertraline-induced Ca<sup>2+</sup> entry was inhibited by nifedipine, La<sup>3+</sup>, Gd<sup>3+</sup>, and SK&amp;F96365. When extracellular Ca<sup>2+</sup> was removed, pretreatment with the endoplasmic reticulum (ER) Ca<sup>2+</sup> pump inhibitor, thapsigargin, or 2, 5-di-tert-butylhydroquinone (BHQ) abolished the sertraline-evoked [Ca<sup>2+</sup>]<sub>i</sub> rise. Incubation with sertraline also abolished the thapsigargin or BHQ-induced [Ca<sup>2+</sup>]<sub>i</sub> rise. Inhibition of phospholipase C (PLC) with U73122 abolished the sertraline-induced [Ca<sup>2+</sup>]<sub>i</sub> rise. At 20–30 µM, overnight treatment with sertraline killed cells in a concentration-dependent manner. The cytotoxic effect of sertraline was not reversed by chelating cytosolic Ca<sup>2+</sup> with 1, 2-bis(2-aminophenoxy)ethane-N, N, N', N'-tetraacetic acid (BAPTA). Annexin V/propidium iodide staining data demonstrate that sertraline (30 µM) evoked apoptosis. Sertraline (20 and 30 µM) also increased levels of reactive oxygen species. Together, in human osteosarcoma cells, sertraline evoked a [Ca<sup>2+</sup>]<sub>i</sub> rise by inducing PLC-dependent Ca<sup>2+</sup> release from the ER and Ca<sup>2+</sup> entry by L-type Ca<sup>2+</sup> channels and store-operated Ca<sup>2+</sup> channels. Sertraline induced cell death that may involve apoptosis by mitochondrial pathways.</p> </abstract> … (more)
- Is Part Of:
- Drug and chemical toxicology. Volume 36:Number 2(2013:Apr.)
- Journal:
- Drug and chemical toxicology
- Issue:
- Volume 36:Number 2(2013:Apr.)
- Issue Display:
- Volume 36, Issue 2 (2013)
- Year:
- 2013
- Volume:
- 36
- Issue:
- 2
- Issue Sort Value:
- 2013-0036-0002-0000
- Page Start:
- 231
- Page End:
- 240
- Publication Date:
- 2013-04
- Subjects:
- Toxicology -- Periodicals
Drugs -- Toxicology -- Periodicals
Toxicology, Experimental -- Periodicals
615.9005 - Journal URLs:
- http://informahealthcare.com ↗
- DOI:
- 10.3109/01480545.2012.710625 ↗
- Languages:
- English
- ISSNs:
- 0148-0545
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3627.985000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3187.xml